E6-18896. Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on extending OMB approval on the existing reporting requirements for the information collection activity entitled “How to Use E-mail to Submit a Notice of Intent to Slaughter For Human Food Purposes.”

    DATES:

    Submit written or electronic comments on the collection of information by January 8, 2007.

    ADDRESSES:

    Submit electronic comments on the collection of information to: http://www.fda.gov/​dockets/​ecomments. Submit written comments on the collection of information to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Denver Presley, Jr., Office of the Chief Information Officer (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1472.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. “Collection of information” is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.

    With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.

    Guidance for Industry on “How to Use E-mail to Submit a Notice of Intent to Slaughter for Human Food Purposes,” Section 512j, Federal Food, Drug, and Cosmetic Act; (OMB Control Number 0910-0450)—Extension

    Section 512(j) of the Federal Food, Drug, and Cosmetic Act (the act), gives FDA the authority to set conditions under which animals treated with investigational new animal drugs may be marketed for food use. Under this authority, the Center for Veterinary Medicine (CVM), issues to a new animal drug sponsor (sponsors) a slaughter authorization letter that sets the terms under which investigational animals may be slaughtered. The United States Department of Agriculture (USDA), also monitors the slaughter of animals treated with investigational new animal drugs under the authority of the Meat Inspection Act (21 U.S.C. 601-95). Sponsors must submit slaughter notices each time investigational animals are presented for slaughter, unless this requirement is waived by an authorization letter ((21 CFR 511.1(b)(5)), (9 CFR 309.17)). These notifications assist CVM and USDA in monitoring the safety of the food supply. Slaughter notices were previously submitted to CVM and USDA on paper. (OMB No. 0910-0450). CVM's guidance on “How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes” provides sponsors with the option to submit a slaughter notice as an e-mail attachment to CVM and USDA by the internet.

    The electronic submission of slaughter notices is part of CVM's ongoing initiative to provide a method for paperless submissions.

    The likely respondents are new animal drug sponsors.

    FDA estimates the burden of this collection of information as follows:

    Table 1.—Estimated Annual Reporting Burden1

    Form No.No. of RespondentsAnnual Frequency per ResponseTotal Annual Responses2Hours per ResponseTotal Hours
    FDA Form #348825.0820.41.82
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    2 Electronic submissions received between July 1, 2005 and June 30, 2006.

    The number of respondents in table 1 of this document is the number of sponsors registered to make electronic submissions (25). The number of total annual responses are based on a review of the actual number of submissions made between July 1, 2005, and June 30, 2006. 2 x hours per response (.41) = .82 total hours.

    Submitting a slaughter notice electronically represents an alternative to submitting a notice of intent to slaughter on paper. The reporting burden for compilation and submission of this information on paper is included in OMB clearance of the information collection provisions of 21 CFR 511.1 (OMB No. 0910-0450). The estimates in Table 1 of this document reflect the burden associated with putting the same information on FDA Form #3488 and resulted from previous discussions with sponsors about the time necessary to complete this form.

    Start Signature

    Dated: November 2, 2006.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E6-18896 Filed 11-7-06; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
11/08/2006
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E6-18896
Dates:
Submit written or electronic comments on the collection of information by January 8, 2007.
Pages:
65532-65533 (2 pages)
Docket Numbers:
Docket No. 2006N-0435
PDF File:
e6-18896.pdf